How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

Neurogen is seeking partnerships in neuroscience, pain and inflammatory diseases

Organization name

Neurogen Corp. business development

Profile

Neurogen is a small molecule drug discovery and development company targeting new drug candidates to improve the lives of patients suffering from pain, insomnia, inflammation, depression and obesity.

They are concentrating their efforts on key therapeutic areas (neuroscience, pain and inflammation) within which clinical indications may be developed for a variety of disorders, balancing risk against potential value.

They believe that their ability to produce multiple generations of  candidates in multiple programs using AIDD (TM) distinguishes Neurogen as a leading drug discovery and development company.

Neurogen's partnering strategy seeks to retain ownership and control of programs as far downstream as possible, balancing risk for the Company while maximizing return for shareholders. They are building capabilities internally to take programs further in clinical development. These capabilities enable them to pursue a flexible business model, using partnered programs when they feel it will be competively and economically advantageous to do so.

When they partner their programs they seek to collaborate with pharmaceutical leaders with demonstrated strenght and resources which complement their own.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries